Red Cedar Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-2,265
Closed -$203K – 88
2022
Q2
$203K Sell
2,265
-673
-23% -$68.2K 0.03% 88
2022
Q1
$326K Hold
2,938
– – 0.05% 88
2021
Q4
$304K Sell
2,938
-4,829
-62% -$559K 0.04% 89
2021
Q3
$974K Hold
7,767
– – 0.13% 59
2021
Q2
$964K Hold
7,767
– – 0.13% 56
2021
Q1
$918K Hold
7,767
– – 0.12% 57
2020
Q4
$910K Buy
+7,767
New +$855K 0.14% 52

Other funds holding MDT

Red Cedar Investment Management's MDT Position: Q3 2022 in Review

Red Cedar Investment Management sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,265 shares — an estimated $203K sold.

Red Cedar Investment Management first reported a position in MDT in Q4 2020 and held it in 7 quarters. The position peaked at $974K in Q3 2021. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Red Cedar Investment Management reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Red Cedar Investment Management sold 2,265 Medtronic shares in Q3 2022, an estimated $203K.
  • Red Cedar Investment Management first reported a position in Medtronic in Q4 2020 and held it in 7 quarters.
  • Red Cedar Investment Management's Medtronic position peaked at $974K in Q3 2021.
  • 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Red Cedar Investment Management's 13F filing for Q3 2022, filed 27 Oct 2022.